Precision Diagnostics Market
Precision Diagnostics Market Forecasts to 2030 - Global Analysis By Type (Direct to Consumer Tests, Esoteric Tests, Genetic Tests and Other Types), Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $79.3 BN |
|
Projected Year Value (2030) |
US $205.7 BN |
|
CAGR (2023 - 2030) |
14.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Precision Diagnostics Market is accounted for $79.3 billion in 2023 and is expected to reach $205.7 billion by 2030 growing at a CAGR of 14.6% during the forecast period. The market for improved diagnostic technologies that enable very precise and customized medical testing is known as the ""precision diagnostics market."" Precision diagnostics entails the molecular analysis of patient samples using advanced methods, including proteomics, genomics, and molecular diagnostics. With this method, genetic variants, biomarkers, and other molecular indicators linked to certain diseases can be precisely identified.
According to the World Health Organization (WHO), in May 2021, 163,312,429 people worldwide were affected by COVID-19.
Market Dynamics:
Driver:
Increasing healthcare awareness
Patients and healthcare professionals' awareness of the revolutionary effect accurate diagnosis can have on treatment results is growing. An increasing number of people are becoming aware of the benefits of early disease detection, customized treatment regimens, and the possibility of better patient outcomes. Additionally, more and more sophisticated patients are asking for access to state-of-the-art diagnostic tools that can offer an in-depth understanding of their molecular health.
Restraint:
High upfront costs
Advanced technology adoption requires large upfront investments in specialized machinery, infrastructure, and skilled employees. Some instances of these are next-generation sequencing and molecular profiling. These higher initial costs might pose an economic challenge for medical facilities, and diagnostic labs and potentially restrict patient access to specific precision diagnostic services. However, the financial burden is further increased by the fact that the expenses extend beyond the purchase of technology and involve thorough training courses for medical professionals.
Opportunity:
Growing prevalence of chronic diseases
Accurate and timely diagnostic tools are becoming more and more necessary due to the rising worldwide burden of diseases like cancer, cardiovascular diseases, and neurological disorders. The identification of certain genetic mutations, biomarkers, and molecular signatures associated with a range of chronic conditions is made possible by precision diagnostics, which includes cutting-edge molecular technology and customized medicine techniques. Additionally, accurate and thorough diagnoses are essential for successful intervention and better patient outcomes since these illnesses often require specialized therapies.
Threat:
Data privacy and security concerns
Ensuring strong data protection measures is crucial because precision diagnostics requires the collection and analysis of extremely sensitive patient information, including genetic and molecular data. Patients and healthcare providers are concerned about the possibility of misuse, data breaches, and unauthorized access to personal health information. However, strict adherence to data protection laws, such as GDPR and HIPAA, is necessary to address these issues, necessitating substantial expenditures in cybersecurity infrastructure.
Covid-19 Impact:
While the pandemic emphasized the significance of rapid and accurate diagnosis, delays in non-urgent diagnostic procedures and the redirection of resources toward COVID-19 testing caused disruptions. Demand for molecular diagnostics, especially PCR-based tests, surged in the industry, but supply chain disruptions and overloaded hospital infrastructures posed problems. Traditional diagnostic settings were also impacted by a shift in emphasis toward telemedicine and remote diagnostics.
The genetic tests segment is expected to be the largest during the forecast period
With the growing popularity of precision medicine, the genetic testing sector held the largest market share. Demand for genetic tests, such as molecular profiling and next-generation sequencing, is rapidly rising. An individual's genetic composition can be fully recognized by these tests, which can detect certain genetic differences, illness susceptibility, and possible treatment reactions. Additionally, the use of genetic tests for illness diagnosis, risk assessment, and treatment planning is being driven by the rising frequency of genetic illnesses and the increasing awareness of individualized healthcare.
The oncology segment is expected to have the highest CAGR during the forecast period
Because molecular testing, liquid biopsies, and genomic profiling have made it possible to identify particular genetic changes and biomarkers linked to various cancer types, the oncology sector is expanding rapidly. With this level of accuracy, oncologists can optimize therapeutic outcomes by customizing treatment plans based on each patient's tumor's unique genetic profile. Accurate diagnostic techniques for oncology are in greater demand due to the rising global prevalence of cancer and our growing understanding of its molecular basis.
Region with largest share:
Because the demand for sophisticated and accurate diagnostic tools has increased due to the rising prevalence of chronic diseases, including cancer and cardiovascular disorders, the Asia-Pacific region is anticipated to hold the largest share of the market over the forecasted period. In addition, the area is experiencing a rise in the middle-class population and healthcare expertise, with a particular emphasis on preventive healthcare practices. Moreover, the precision diagnostic tenets of tailored and targeted interventions for better patient outcomes are in accordance with this movement in healthcare perspectives.
Region with highest CAGR:
The Asia-Pacific region is growing profitably as a result of the rapid advancement in technology and the growing availability of healthcare services. Nations like China, Japan, and India have invested large investments in R&D, infrastructure, and healthcare, providing a climate that is favorable to the adoption of cutting-edge diagnostic technology. The Asia Pacific region will definitely be a major force behind the growth and expansion of the precision diagnostics market on a global scale as it continues to prioritize the development of healthcare infrastructure, invest in research and innovation, and experience a paradigm shift towards precision medicine.
Key players in the market
Some of the key players in Precision Diagnostics market include Abbott, Bayer AG, Koninklijke Philips N.V., Lantheus Medical Imaging, Inc., Novartis AG, QIAGEN, Quest Diagnostics Incorporated, Sanofi, Siemens Healthineers AG and Swiss Precision Diagnostics GmbH.
Key Developments:
In October 2023, Bayer AG has entered into an antibody discovery, option, and license agreement with Twist Bioscience Corporation, a company offering high-quality synthetic DNA using its silicon platform.
In September 2023, Abbott signs definitive agreement to acquire Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. As part of the acquisition, Abbott will use Bigfoot Unity with its FreeStyle Libre technology, which uses a customer smartphone app connected to a cloud-based online portal.
In May 2023, Bayer has secured a long-term structured renewable energy credit purchase agreement with Cat Creek Energy that will generate 1.4 terawatt-hours of clean electricity annually, equivalent to the energy consumption of 150,000 households.
Types Covered:
• Direct to Consumer Tests
• Esoteric Tests
• Genetic Tests
• Other Types
Applications Covered:
• Cardiovascular
• Immunology
• Oncology
• Respiratory Diseases
• Other Applications
End Users Covered:
• Clinical Laboratories
• Homecare
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Precision Diagnostics Market, By Type
5.1 Introduction
5.2 Direct to Consumer Tests
5.3 Esoteric Tests
5.4 Genetic Tests
5.5 Other Types
6 Global Precision Diagnostics Market, By Application
6.1 Introduction
6.2 Cardiovascular
6.3 Immunology
6.4 Oncology
6.5 Respiratory Diseases
6.6 Other Applications
7 Global Precision Diagnostics Market, By End User
7.1 Introduction
7.2 Clinical Laboratories
7.3 Homecare
7.4 Hospitals
7.5 Other End Users
8 Global Precision Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abbott
10.2 Bayer AG
10.3 Koninklijke Philips N.V.
10.4 Lantheus Medical Imaging, Inc.
10.5 Novartis AG
10.6 QIAGEN
10.7 Quest Diagnostics Incorporated
10.8 Sanofi
10.9 Siemens Healthineers AG
10.10 Swiss Precision Diagnostics GmbH
List of Tables
1 Global Precision Diagnostics Market Outlook, By Region (2021-2030) ($MN)
2 Global Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
3 Global Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
4 Global Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
5 Global Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
6 Global Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
7 Global Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
8 Global Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
9 Global Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
10 Global Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
11 Global Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
12 Global Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
13 Global Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
14 Global Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
15 Global Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
16 Global Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
17 Global Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
18 North America Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
19 North America Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
20 North America Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
21 North America Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
22 North America Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
23 North America Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
24 North America Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
25 North America Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
26 North America Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
27 North America Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
28 North America Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
29 North America Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
30 North America Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
31 North America Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
32 North America Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
33 North America Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
34 North America Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
35 Europe Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
36 Europe Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
37 Europe Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
38 Europe Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
39 Europe Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
40 Europe Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
41 Europe Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
42 Europe Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
43 Europe Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
44 Europe Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
45 Europe Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
46 Europe Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
47 Europe Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
48 Europe Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
49 Europe Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
50 Europe Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
51 Europe Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
52 Asia Pacific Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
53 Asia Pacific Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
54 Asia Pacific Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
55 Asia Pacific Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
56 Asia Pacific Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
57 Asia Pacific Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
58 Asia Pacific Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
59 Asia Pacific Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
60 Asia Pacific Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
61 Asia Pacific Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
62 Asia Pacific Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
63 Asia Pacific Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
64 Asia Pacific Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
65 Asia Pacific Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
66 Asia Pacific Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
67 Asia Pacific Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
68 Asia Pacific Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
69 South America Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
70 South America Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
71 South America Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
72 South America Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
73 South America Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
74 South America Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
75 South America Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
76 South America Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
77 South America Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
78 South America Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
79 South America Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
80 South America Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
81 South America Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
82 South America Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
83 South America Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
84 South America Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
85 South America Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
86 Middle East & Africa Precision Diagnostics Market Outlook, By Country (2021-2030) ($MN)
87 Middle East & Africa Precision Diagnostics Market Outlook, By Type (2021-2030) ($MN)
88 Middle East & Africa Precision Diagnostics Market Outlook, By Direct to Consumer Tests (2021-2030) ($MN)
89 Middle East & Africa Precision Diagnostics Market Outlook, By Esoteric Tests (2021-2030) ($MN)
90 Middle East & Africa Precision Diagnostics Market Outlook, By Genetic Tests (2021-2030) ($MN)
91 Middle East & Africa Precision Diagnostics Market Outlook, By Other Types (2021-2030) ($MN)
92 Middle East & Africa Precision Diagnostics Market Outlook, By Application (2021-2030) ($MN)
93 Middle East & Africa Precision Diagnostics Market Outlook, By Cardiovascular (2021-2030) ($MN)
94 Middle East & Africa Precision Diagnostics Market Outlook, By Immunology (2021-2030) ($MN)
95 Middle East & Africa Precision Diagnostics Market Outlook, By Oncology (2021-2030) ($MN)
96 Middle East & Africa Precision Diagnostics Market Outlook, By Respiratory Diseases (2021-2030) ($MN)
97 Middle East & Africa Precision Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
98 Middle East & Africa Precision Diagnostics Market Outlook, By End User (2021-2030) ($MN)
99 Middle East & Africa Precision Diagnostics Market Outlook, By Clinical Laboratories (2021-2030) ($MN)
100 Middle East & Africa Precision Diagnostics Market Outlook, By Homecare (2021-2030) ($MN)
101 Middle East & Africa Precision Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
102 Middle East & Africa Precision Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
